---
title: "Chemomab Therapeutics: Merger creates an AI-powered precision medicine leader advancing nebokitug for RA with $30M funding"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292066923.md"
description: "A merger will combine AI-driven precision medicine and a novel anti-CCL24 antibody to advance a Phase 2 RA trial, with a $150M valuation and $30M new investment. The deal aims to create the first precision medicine for RA, leveraging strong data assets and commercial platforms.Original document: Chemomab Therapeutics Press release — Jul. 8 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-08T12:17:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292066923.md)
  - [en](https://longbridge.com/en/news/292066923.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292066923.md)
---

# Chemomab Therapeutics: Merger creates an AI-powered precision medicine leader advancing nebokitug for RA with $30M funding

A merger will combine AI-driven precision medicine and a novel anti-CCL24 antibody to advance a Phase 2 RA trial, with a $150M valuation and $30M new investment. The deal aims to create the first precision medicine for RA, leveraging strong data assets and commercial platforms.

Original document: Chemomab Therapeutics Press release — Jul. 8 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [CMMB.US](https://longbridge.com/en/quote/CMMB.US.md)

## Related News & Research

- [How the 'Nostradamus of AI' failed to spot a market crash](https://longbridge.com/en/news/294580418.md)
- [Okta acquires AI startup Permiso for about $200M: report](https://longbridge.com/en/news/294406094.md)
- [Meet the Gen Z AI whiz at the center of a hedge fund meltdown](https://longbridge.com/en/news/294425537.md)
- [ServiceNow’s Q2 Earnings Showed It’s More Than an AI Stock](https://longbridge.com/en/news/294095449.md)
- [Investors Are Looking at AI the Wrong Way](https://longbridge.com/en/news/294586655.md)